Zusammenfassung
Asthma bronchiale ist eine der häufigsten chronischen Erkrankungen bei Kindern und Jugendlichen mit einer Prävalenz von rund 10 % in den deutschsprachigen Ländern. Typische Symptome sind pfeifende Atemgeräusche, Enge im Brustkorb und Atemnot. Die Diagnose wird klinisch gestellt; der wichtigste objektive Parameter ist der Nachweis der reversiblen Atemwegsobstruktion. Verschiedene Leitlinien stehen national und international für die Therapie zur Verfügung. Neben der medikamentösen Therapie ist das nichtmedikamentöse Management mit Allergenkarenz, Compliance-Überprüfung, Vermittlung der richtigen Inhalationstechnik und umfassender strukturierter Patientenschulung von großer Bedeutung.
Abstract
Bronchial asthma is one of the most common chronic diseases in childhood with a prevalence of approximately 10 % in German-speaking countries. Typical symptoms are wheezing, narrowing of the chest and dyspnea. The diagnosis is made based on clinical symptoms and the most important objective parameter is proof of airway obstruction. National and international guidelines provide a standardized treatment. The main pillars of management are anti-inflammatory drugs, beta- 2- agonists, compliance testing, instruction on the correct inhalation technique, comprehensively structured patient educational programs and in selected cases allergen immunotherapy.
Literatur
Asher MI et al (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood. ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368:733–743
Eder W et al (1998) Prävalenz und Schweregrad von Asthma bronchiale, allergischer Rhinitis und atopischer Dermatitis bei Salzburger Schulkindern. Wien Klin Wochenschr 110/19:669–677
Lai CK et al (2009) Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 64(6):476–483
Riedler J et al (1998) Prevalence of bronchial hyperresponsiveness to 4.5 % saline and its relation to asthma and allergy symptoms in Austrian children. Eur Respir J 11:355–360
Hamelmann E et al (2014) Asthma bronchiale. In: Mutius E von, Gappa M, Eber E, Frey U (Hrsg) Pädiatrische Pneumologie, 3. Aufl. Springer, Berlin, S 553–577
Illi S et al (2006) Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 368:763–770
Martinez FD et al (1995) Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 332(3):133–138
Sears MR et al (2003) A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349(15):1414–1422
Castro-Rodriguez JA (2011) The Asthma Predictive Index: early diagnosis of asthma. Curr Opin Allergy Clin Immunol 11(3):157–161
Guerra S et al (2004) Persistence of asthma symptoms during adolescence: role of obesity and age at the onset of puberty. Am J Respir Crit Care Med 170(1):78–85
Spahn JD et al (2008) Clinical assessment of asthma progression in children and adults. J Allergy Clin Immunol 121(3):548–557
Eder W et al (2006) The asthma epidemic. N Engl J Med 355(21):2226–2235
Riedler J et al (2001) Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358:1129–1133
Bisgaard H et al (2007) Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357(15):1487–1495
Hansen G et al (2013) Asthma bronchiale im Kindesalter. Monatsschr Kinderheilkd 161:390–398
GINA Report (2014) Global strategy for asthma management and prevention. http://www.ginasthma.org
Nationale Versorgungsleitlinie (2011) Asthma Langfassung, 2. Aufl. Version 1.3, Juli. http://www.versorgungsleitlinien.de/themen/asthma/pdf/nvl_asthma_lang.pdf
Riedler J et al (2008) Leitlinie zur Behandlung des Asthma bronchiale bei Kindern und Jugendlichen. Wien Klin Wochenschr 120:54–60
Brand PL et al (2008) Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 32(4):1096–1110
Götz M et al (2006) Rezidivierende obstruktive Bronchitis und Asthma bronchiale im Vorschulalter. Wien Klin Wochenschr 118/9–10:302–306
Roth S et al (2009) Empfehlungen zur Behandlung der obstruktiven Atemwegserkrankungen im Kindesalter (SGPP/PIA-CH 2009). Paediatrica 20:44–51
Castro-Rodriguez JA, Rodrigo GJ (2009) Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 123:e519–e525
Guilbert TW et al (2011) Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol 128(5):956–963
Kelly HW et al (2012) Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 367(10):904–912
Zhang L et al (2014) Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev 8:CD009471
Nwokoro C et al (2014) Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Lancet Respir Med 2:796–803
Guilbert TW et al (2006) Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 354:1985–1997
Cates CJ et al (2012) Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews. Cochrane Database Syst Rev CD010005
Ducharme FM et al (2010). Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev 4:CD005533
Gardia Garcia ML et al (2005) Montelukast compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma. The MOSAIC Study. Pediatrics 116:360–369
Szefler S et al (2005) Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115:233–242
Lemanske RF Jr et al (2010) Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 362(11):975–985
Chauhan et al (2013) Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma. Cochrane Database Syst Rev 10:CD009585
Wolf F et al (2008) Educational interventions for asthma in children. Cochrane Database Syst Rev 4:CD000326
Abramson MJ et al (2010) Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 8:CD001186
Pfarr O et al (2014) Leitlinie zur (allergen-) spezifischen Immuntherapie bei IgE-vermittelten allergischen Erkrankungen. Allergo J 23:282–319
Gotzsche PC et al (2011) House dust mite control measures for asthma. Cochrane Database Syst Rev 10:CD001187
Riedler J (2014) Pediatric asthma- do we need more innovation for treatment? Pediatr Allergy Immunol 25:19–20
Einhaltung ethischer Richtlinien
Interessenkonflikt. Chiesi: bezahlte Vorträge, Reiseunterstützung zu Kongressen; MSD: bezahlte Vorträge; Stallergen: Reiseunterstützung zu Kongressen; MEDA: bezahlte Vorträge; Fa. Pari, MEDA, Chiesi und Forest: Sponsoring von nationalen Fortbildungsveranstaltungen.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riedler, J. Asthma bronchiale bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 163, 833–846 (2015). https://doi.org/10.1007/s00112-015-3373-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-015-3373-0
Schlüsselwörter
- Chronische obstruktive Lungenerkrankungen
- Atemwegsobstruktion
- „Wheezing“
- Bronchiale Hyperreagibilität
- Sympathikomimetikum